Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Sees Large Increase in Short Interest

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 12,200 shares, a growth of 144.0% from the December 15th total of 5,000 shares. Based on an average daily trading volume, of 5,300 shares, the days-to-cover ratio is currently 2.3 days.

Clinuvel Pharmaceuticals Trading Up 1.6 %

OTCMKTS CLVLY traded up $0.12 during trading hours on Wednesday, reaching $7.39. 1,429 shares of the company’s stock traded hands, compared to its average volume of 6,161. Clinuvel Pharmaceuticals has a 52-week low of $6.80 and a 52-week high of $11.40. The firm has a 50-day simple moving average of $8.13 and a 200 day simple moving average of $9.14.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).